| P50 | author | Bastian Schirmer | Q60971596 |
| P2093 | author name string | Dirk Wedekind | |
| | Detlef Neumann | |
| | Silke Glage | |
| P2860 | cites work | NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling. | Q54194314 |
| | A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease | Q57232080 |
| | IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice | Q60998067 |
| | Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice | Q64388661 |
| | Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus | Q73086329 |
| | Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18 | Q74477197 |
| | A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells | Q74557513 |
| | Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines | Q74602787 |
| | IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production | Q77367658 |
| | Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis | Q78505529 |
| | Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms | Q79319535 |
| | Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation | Q80102514 |
| | Interleukin-18 receptor signaling is not required for autoantibody production and end-organ disease in murine lupus | Q81484695 |
| | High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus | Q84311481 |
| | IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease | Q33715791 |
| | The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? | Q34127758 |
| | Association of IL-18 polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Asian populations: a meta-analysis | Q34478393 |
| | Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. | Q34566135 |
| | Association of interleukin-18 (-137G/C) polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis | Q34893105 |
| | Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice | Q35393618 |
| | The genetics of human systemic lupus erythematosus | Q35575146 |
| | Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains | Q36342054 |
| | Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice | Q36351961 |
| | Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus | Q36403146 |
| | Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury | Q36977361 |
| | Interleukin-18 and IL-18 binding protein | Q37220336 |
| | Roles of interferon-gamma and interleukin-4 in murine lupus | Q37365961 |
| | Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice | Q37377479 |
| | The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 |
| | Cutaneous lupus erythematosus: recent lessons from animal models | Q37778643 |
| | Cytokine inhibition as a strategy for treating systemic lupus erythematosus | Q38064143 |
| | The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside | Q38085723 |
| | IL-18 in inflammatory and autoimmune disease | Q38124723 |
| | Interleukin-18, more than a Th1 cytokine | Q38166154 |
| | IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury | Q38957793 |
| | Interleukin-12 upregulates the IL-18Rbeta chain in BALB/c thymocytes | Q40780323 |
| | Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain | Q40822216 |
| | Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. | Q41509132 |
| | Defective NK cell activity and Th1 response in IL-18-deficient mice | Q43595287 |
| | Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis | Q44130510 |
| | Blockade of IL-18 receptor signaling delays the onset of autoimmune disease in MRL-Faslpr mice | Q45094809 |
| | IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. | Q45933733 |
| | Control of animal pain and distress in cancer and toxicologic research | Q46727769 |
| | Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus | Q47417555 |
| | IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice | Q47909571 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney failure | Q476921 |
| P304 | page(s) | e0140173 | |
| P577 | publication date | 2015-10-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Deletion of IL-18 Expression Ameliorates Spontaneous Kidney Failure in MRLlpr Mice | |
| P478 | volume | 10 | |